Resolution Of April 20, 2012, Of The Pablo De Olavide University, Which Publishes Curriculum Of Master In Health Biotechnology.

Original Language Title: Resolución de 20 de abril de 2012, de la Universidad Pablo de Olavide, por la que se publica el plan de estudios de Máster en Biotecnología Sanitaria.

Read the untranslated law here: http://www.boe.es/buscar/doc.php?id=BOE-A-2012-6859

The publication of the resolution of October 18, 2010, of the Pablo de Olavide University in Seville, which was made public the curriculum of the Master in «Health biotechnology» took place in the «Official Gazette» on November 20, 2010 and the «Bulletin official of the Junta de Andalucía» on November 19, 2010.

According to the collected article 28 of Royal Decree 861/2010 of 2 July, amending Royal Decree 1393 / 2007, of 29 October, which establishes the planning of official university education, the University Pablo de Olavide in Seville, proposed to the Ministry of education about changes in the curriculum of the aforementioned Master.

Having received a favourable report from the National Agency for quality assessment and accreditation (ANECA) do not affect changes in the curriculum of the Master to nature or to the objectives of the title registered in the register of universities, centres and degrees (RUCT), this Rectorate resolved: order the publication of the new curriculum leading to the obtaining of the official title of Master's degree in «Health biotechnology».

The plan of studies referred to in the present resolution shall be structured as contained in the annex.

Seville, April 20, 2012.-El Rector, Juan Jiménez Martínez.

Annex Plan of studies leading to the title of Master in «Health biotechnology» (Royal Decree 1393 / 2007, annex I, section 5.1.) Structure of the teachings) distribution of curriculum in ECTS credits, by type of external credits ECTS obligatory 35 electives 37 practices subject matter - work order to Master 18 credits total 90 * dealt with 12 ECTS credits of electives Externships.

General structure of the plan of molecular matter character C. ECTS Bases of disease: Bases disease OBL 2.5 Bases molecular genetics and molecular cancer OBL 2.5 Bases cell of aging and degenerative diseases OBL 2.5 molecular and cellular Bases of diseases autoimmune OBL 2.5 diseases metabolic and cardiovascular risks OBL 2.5 diseases rare OBL 2.5 methods practical in the study and analysis of the pathologies OBL. 5






Pathogenesis and diagnosis of infectious disease OPT 5 technology for diagnosis and research in biomedicine: applied genomics OBL. 5 fluorescent techniques for application of biomolecules OBL. 5 nanotechnology OPT 5 omics applied to biomedicine OPT 5. application of the agencies model in health biotechnology: animal models in biotechnology OBL. 5 mechanism of tissue differentiation and Morphogenesis OPT 5 tissue regeneration OPT





5 generation of new drugs strategy: bioengineering tissues OPT 5 cell therapy OPT 5 strategies for generation of new drugs OPT 5 2nd course vocational and business training in biotechnology: entrepreneurship and technology transfer * OPT 5 internships OPT 12 research training in biotechnology: introduction to research OPT 12






Master thesis: work end of OBL 18 master * this subject is taught in first year.